Resources

The latest in immuno research, from the discovery & development of cell & antibody therapies through to omics-based approaches and clinical case studies

Biomarkers in Immuno-Oncology

New Multi-Omic AI-Driven Initiative for Immuno-Oncology Biomarker Development

The team aims to establish a consortium of cancer centres to join the project of developing biomarkers from multi-omic analysis.
Biomarkers in Immuno-Oncology

Oncolytic Virus Immunotherapy: A Revolutionary Approach in Immuno-Oncology

Explore the cutting-edge of oncolytic virus immunotherapy in immuno-oncology: the viruses revolutionizing cancer treatment and the promise they hold for future therapies.
Biomarkers in Immuno-Oncology

NeoGenomics: Connect With Us to Explore How Our Oncology Data and Expertise Can Help Your Team

Data-driven insights from the largest volume cancer-testing lab in the U.S.
Biomarkers in Immuno-Oncology

Simplify Spatial Imaging Maxpar IMC Cell Segmentation Kit

High-plex imaging starts with robust cell segmentation
Biomarkers in Immuno-Oncology

Bioanalytical Solutions for CAR-T and NK Cell Therapies

Synexa Life Sciences is a bioanalytical and biomarker services laboratory specializing in the development and validation of complex and custom designed assays with progression into clinical trial sample analysis.
Biomarkers in Immuno-Oncology

Synexa Life Sciences: Bioanalytical Solutions for Immuno-oncology Therapeutics

Global leaders in specialist biomarker and bioanalysis research services.
Biomarkers in Immuno-Oncology

Synexa Biomarker and Bioanalytical Solutions

Complex solutions delivered on time and within budget.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things immuno